Please enable Javascript
Viktor Grünwald, MD, PhD
Viktor Grünwald, MD, PhD, University Hospital Essen
Articles by Viktor Grünwald, MD, PhD
Patterns of Progression, Subsequent Therapy in the CLEAR Trial
Viktor Grünwald, MD, PhD
Advanced Renal Cell Carcinoma
|
August 19, 2024
Dr. Grünwald showcases patterns of progression and subsequent therapy for patients receiving len/pembro for aRCC.
View More
CheckMate 914 Part B: Nivolumab Monotherapy for Localized RCC After Nephrectomy
Viktor Grünwald, MD, PhD
ASCO GU Symposium 2024
|
January 30, 2024
Dr. Grünwald describes the CheckMate 914 Part B analysis and investigating adjuvant nivo for patients with localized RCC.
View More
CLEAR and Navigating the Frontline Combination Approaches for Advanced RCC
Viktor Grünwald, MD, PhD
Advanced Renal Cell Carcinoma
|
May 1, 2024
Dr. Grünwald details the CLEAR study and a subgroup analysis on the efficacy of lenvatinib/pembrolizumab for aRCC.
View More